Docetaxel and gemcitabine released for cancer chemotherapy

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1996年 / 53卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1643 / &
页数：2
相关论文
共 50 条
  • [1] SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer
    P A Vasey
    R Atkinson
    R Osborne
    D Parkin
    R Symonds
    J Paul
    L Lewsley
    R Coleman
    N S Reed
    S Kaye
    G J S Rustin
    British Journal of Cancer, 2006, 94 : 62 - 68
  • [2] SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer
    Vasey, PA
    Atkinson, R
    Osborne, R
    Parkin, D
    Symonds, R
    Paul, J
    Lewsley, L
    Coleman, R
    Reed, NS
    Kaye, S
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2006, 94 (01) : 62 - 68
  • [3] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PH
    De Jong, RS
    Honkoop, A
    Rodenburg, C
    Rooda, SE
    Coenen, J
    De Jong, PC
    Douma, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 74S - 74S
  • [4] Salvage chemotherapy of metastatic breast cancer with docetaxel and Gemcitabine: A multicenter phase II trial
    Mavroudis, D
    Malamos, N
    Giannakakis, T
    Alexopoulos, A
    Potamianou, A
    Rigatos, G
    Kosmas, C
    Sarra, E
    Papadouris, S
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 19 - 19
  • [5] DOCETAXEL AND GEMCITABINE AS FIRST-LINE CHEMOTHERAPY IN GASTRIC CANCER: AN EXAMPLE OF TRANSLATIONAL RESEARCH
    Fabbri, Muller
    Ravaioli, Elena
    Milandri, Carlo
    Passardi, Alessandro
    Monticelli, Carla
    Fabbri, Francesco
    Rosetti, Paola
    Amadori, Dino
    ANNALS OF ONCOLOGY, 2004, 15 : 72 - 72
  • [6] Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer
    Georgoulias, VA
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 18 - 24
  • [7] SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer
    Symonds, R. P.
    Davidson, S. E.
    Chan, S.
    Reed, N. S.
    McMahon, T.
    Rai, D.
    Harden, S.
    Paul, J.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 105 - 109
  • [8] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [9] Posterior Segment Toxicity after Gemcitabine and Docetaxel Chemotherapy
    Valeshabad, Ali Kord
    Mieler, William F.
    Setlur, Vikram
    Thomas, Merina
    Shahidi, Mahnaz
    OPTOMETRY AND VISION SCIENCE, 2015, 92 (05) : 654 - 654
  • [10] Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer
    Takahiro Yoneyama
    Atsushi Imai
    Shingo Hatakeyama
    Yasuhiro Hashimoto
    Takuya Koie
    Chikara Ohyama
    International Journal of Clinical Oncology, 2015, 20 : 1179 - 1184
12345